Who
Padmanabh P. Bhatt
Sr. VP of IP, CSO
Company insider
Files Form 4 as: Sr. VP of IP, CSO, Supernus Pharmaceuticals.
In numbers
- Trades disclosed
- 250
- Buys
- 0
- Sells
- 41
- Bought
- $0
- Sold
- $25.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jun 2012
- Last trade
- 12 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $54K1,158 at $46.57 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $54K1,158 at $46.57 | filing |
| 29 Jul 2026filed 31 Jul 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 29 Jul 2026filed 31 Jul 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $286K7,250 at $39.40 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $339K6,838 at $49.55 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $21K412 at $50.48 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,250 at $0.00 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —7,250 at $0.00 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $286K7,250 at $39.40 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $339K6,838 at $49.55 | filing |
| 18 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $21K412 at $50.48 | filing |
| 17 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.4M27,710 at $49.95 | filing |
| 17 Mar 2026filed 18 Mar 2026 | SUPN Supernus PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.1M22,290 at $50.73 | filing |
| 17 Mar 2026filed 18 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —22,750 at $0.00 | filing |
| 17 Mar 2026filed 18 Mar 2026 | SUPN Supernus Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —12,250 at $0.00 | filing |
News
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026SUPN · manilatimes.net · 19 Oct 2026Supernus Pharmaceuticals (NASDAQ:SUPN) vs. Kiora Pharmaceuticals (NASDAQ:KPRX) Critical SurveySUPN · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Padmanabh P. Bhatt; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.